NHS Weight Loss Injections: Eligibility, Costs & Safe Access Guide (2026)
For many adults in the UK, achieving sustainable weight loss through diet and exercise alone remains a genuine challenge. In recent years, the NHS has recognised new prescription injectable treatments that can support weight management when used under medical supervision. However, confusion around who actually qualifies, what the real costs are (NHS prescription charge vs private fees), and how to apply safely is widespread. This guide provides a clear, factual overview of the two main eligibility criteria for NHS-supported treatment, realistic cost expectations, the pros and cons of these medications, the step-by-step application process, and available financial support options.
Injectable weight loss treatments — including medications like semaglutide (Wegovy) and tirzepatide (Mounjaro) — are now available through both NHS and private routes in the UK. As demand continues to grow and guidance evolves heading into 2026, knowing where you stand on eligibility, costs, and safety has never been more important.
Who Qualifies? Two Key NHS Eligibility Criteria
Access to weight loss injections through the NHS is not universal. Two primary eligibility criteria currently shape who can be considered. First, a person typically needs a Body Mass Index (BMI) of 35 or above, though this threshold may be lower for individuals from certain ethnic backgrounds, such as South Asian or Black African heritage, where health risks appear at lower BMIs. Second, patients must have at least one weight-related health condition, such as type 2 diabetes, hypertension, or sleep apnoea.
At present, NHS prescribing of these medications is largely channelled through specialist weight management services rather than GP surgeries. NHS England has been rolling out a phased approach, meaning availability may vary depending on your local Integrated Care Board (ICB). Not everyone who meets the criteria will be seen immediately, as services are managing significant demand.
NHS vs Private Costs: What Influences the Final Price You Pay?
Cost is one of the most significant factors for people exploring this treatment. Through the NHS, eligible patients may receive prescriptions at the standard prescription charge (currently £9.90 per item in England as of 2025), or potentially for free if they qualify for an exemption. However, NHS access remains limited and is not yet widely available for all qualifying patients.
Private treatment is considerably more expensive. Monthly costs for medications like Wegovy or Mounjaro through private providers can range from approximately £150 to £300 or more per month, depending on the provider, dosage, and any included consultation fees. Prices can also vary based on whether the provider is a digital health platform or a traditional in-person clinic.
| Medication | Provider Type | Estimated Monthly Cost |
|---|---|---|
| Wegovy (semaglutide) | NHS (via specialist service) | £9.90 per prescription or free (if exempt) |
| Wegovy (semaglutide) | Private clinic / online platform | £200–£300+ per month |
| Mounjaro (tirzepatide) | NHS (limited availability) | £9.90 per prescription or free (if exempt) |
| Mounjaro (tirzepatide) | Private clinic / online platform | £150–£280+ per month |
| Saxenda (liraglutide) | Private clinic | £120–£250+ per month |
Prices, rates, or cost estimates mentioned in this article are based on the latest available information but may change over time. Independent research is advised before making financial decisions.
Pros and Cons: Benefits, Side Effects & Long-Term Realities
These medications have shown clinically significant results in trials. Semaglutide, for example, has been associated with an average body weight reduction of around 15% in clinical studies when combined with lifestyle changes. Beyond weight loss, benefits can include improved blood sugar control, reduced cardiovascular risk, and better joint health.
However, side effects are common and should not be minimised. Nausea, vomiting, constipation, and fatigue are frequently reported, particularly in the early weeks of treatment. More serious but less common risks include pancreatitis and gallbladder issues. Long-term use is still being studied, and it is widely acknowledged that stopping the medication can lead to weight regain if lifestyle changes have not been embedded. These are not quick fixes — they are long-term medical tools.
How to Apply & How to Choose a Safe Provider
For NHS access, the starting point is usually your GP, who can refer you to a specialist weight management service if you meet the criteria. Given current demand, waiting times can be lengthy. Alternatively, some ICBs have specific referral pathways that your GP can guide you through.
For private treatment, choosing a regulated provider is essential. Look for clinics and online platforms registered with the Care Quality Commission (CQC). Prescribers should be qualified healthcare professionals — doctors, nurse prescribers, or pharmacists — registered with the General Medical Council (GMC) or equivalent bodies. Avoid providers that do not require a consultation or medical history review before issuing a prescription, as this is a significant safety red flag.
Financial Support: Prescription Charge Exemptions & Subsidies
If you do access treatment through the NHS, there are several ways you may be exempt from paying the standard prescription charge. These include being under 16 or over 60, being pregnant or having recently given birth, holding a valid Medical Exemption Certificate for certain conditions, or receiving qualifying benefits such as Universal Credit or income-related Employment and Support Allowance.
For those who pay for prescriptions regularly, a Prescription Prepayment Certificate (PPC) can reduce overall costs significantly. As of 2025, a 12-month PPC costs around £111.60 and covers all NHS prescriptions regardless of how many items you receive. This can be relevant if you are receiving treatment alongside other ongoing medications.
Navigating access to weight loss injections in the UK requires a clear understanding of medical eligibility, cost realities, and provider standards. Whether you pursue treatment through the NHS or a regulated private route, prioritising safety and informed decision-making will always serve you better than seeking the fastest or cheapest option available.
